Medipharm Labs Corp T.LABS

Vote "NO" on proxy form except for auditors

[piduks]

Management has failed shareholders on 3 different occassions.

1) Failure to disclose expanded manufacturing agreement with Avicanna including details of such deal
2) Year end CC managment clearly stated they would reveal more information to shareholders once the second approval from Brazil was received.  At the recent Q1 CC it was stated the second approval from Brazil was received and managment has failed to disclose to shareholders details of the new drugs and other pertinent information
3) Management stated during the year end CC that the share price was undervalued and has failed it's shareholders by initiating a stock buy back program.

Vote "NO" on the proxy and send them a message.

[unplugged1]

This post has been removed in accordance with Community Policy

[lscfa]

Overpaid execs too

[unplugged1]

Yep, they've treated retail terribly voting against all of them.

[subaru1]

You cann't it say any better.